Phyllis Gimotty, PhD
|Office Location||631, Blockley Hall|
|CCEB Appointment||Senior Scholar, Biostatistics|
|Primary Faculty Appointment||Professor of Biostatistics at HUP, University of Pennsylvania Perelman SOM|
Dr. Gimotty's research focuses on statistical methods and their applications in cancer translational research, prevention and control, and risk assessment. She is currently the Biometrics Core Director for the Wistar/Penn SPORE on Skin Cancer collaborates with cancer research investigators nationally and internationally. Her primary research interests include categorical and survival analysis, model assessment, classification trees, longitudinal data, evaluating diagnostic tests and methods for incomplete data. She currently is a co-principal investigator on a project to use novel biostatistical methods to identify new prognostic biomarkers for melanoma.
Gimotty PA, Botbyl J. Soong S. Guerry D. A population-based validation of the American Joint Committee on Cancer melanoma staging system. Journal of Clinical Oncology 2005; 23(31):8065-8075.
Kruper LL, Spitz FR, Czerniecki BJ, Fraker DL, Blackwood-Chirchir A, Ming ME, Elder DE, Elenitsas R, Guerry D, Gimotty PA. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma. Cancer 2006; 107(10): 2436-2445.
Gimotty PA, Elder DE, Fraker DL, Botbyl JD, Sellers K, Elenitsas R, Ming ME, SchuchterL, Spitz FR, Czerniecki BJ, Guerry D. Identification of high risk patients among those diagnosed with thin cutaneous melanomas. Journal of Clinical Oncology. 2006; 25(9): 1129-1134.
Andreadis C, Gimotty PA, Wahl P, Hammond R, Houldsworth J, Schuster SJ, Rebbeck TR. Members of the glutathione and ABC-transporter families are associated with clinical outcome inpatients with diffuse large B-cell lymphoma. Blood. 2007; 109(8): 3409-3416.
Gimotty PA, Elder DE, Fraker DL, Botbyl JD, Sellers K, Elenitsas R, Ming ME, SchuchterL, Spitz FR, Czerniecki BJ, Guerry D. Identification of high risk patients among those diagnosed with thin cutaneous melanomas. Journal of Clinical Oncology. 2007; 25(9): 1129-1134.